Eli lily’s drug passes 2nd trial with flying colors targeted to reduce obesity

Shots, Health News from NPR, August 21, 2023:  Ozempic and Wegovy, the diabetes and weight loss drugs created a buzz in the summers of 2022. Two clinical trials result on similar medication by pharmaceutical giant Eli Lilly astonished the doctors. Tirzepatide, traded as Mounjaro, specific for diabetes, eventually showed higher weight loss. Participants had unprecedently lost higher weight accounting to 21% of their body weight. The trial results showed the marked impact of medication on obesity including the requirement for ongoing treatment in order to maintain weight loss without diabetes. The drug is presently available in an injectable prescribed medicine form for Type 2 Diabetes people.